Provisional Agenda
(subject to change)
Day 1: Wednesday 13th September
0830-0915: Registration, welcome coffee and networking
0915: Housekeeping
0920: Opening by Professor Martha Clokie
Session 1: Molecular and structural biology, evolution
Chair: Professor Anders Nilsson
0930: Dr Mark J van Raaij, Centro Nacional de Biotecnologia – CSIC, Spain
Title: Crystallographic structures of bacteriophage receptor-binding proteins
1000: Dr Guoqing Xia, The University of Manchester, UK
Title: How a germ catches a virus? An essential role for the baseplate protein Gp45 in phage adsorption to Staphylococcus aureus
1030: Professor David Robertson, University of Manchester, UK
Title: TBA
1100: Refreshments, posters and networking
1130: Professor Alfonso Jaramillo, University of Warwick, UK
Title: Engineering phages and their hosts for the directed evolution of biomolecules
Session 2: Phage-host interaction
Chair: Professor David Robertson
1200: Professor Grzegorz Wegrzyn, University of Gdansk, Poland
Title: Bacteriophage biodiversity – usual and unusual phages isolated from environmental samples
1230: Dr Chloe James, University of Salford, UK
Title: The Role of Temperate Bacteriophages in the Diversification of Pseudomonas aeruginosa Populations during Infection
1300: Dr Surang Chankhamhaengdecha, Mahidol University, Thailand
Title: Characterization of bacteriophage of Clostridium difficile and investigation of bacteriophage-host interactions
1320: Lunch, posters and networking
Session 3: Diagnostics, therapy, antimicrobials
Chair: Professor Martha Clokie
1420: Mr Ahmed Dowah, University of Leicester, UK
Title: Identification of Clostridium difficile bacteriophage tail fiber proteins
1450: Dr Stefan Miller, Lisando GmbH, Germany
Title: Colistin resistant mcr-1-positive Escherichia coli isolates: No resistance development against the highly bactericidal Artilysin® Art-x01
1520: Dr Jinyu Shan, University of Leicester, UK
Title: Borrelia bacteriophages for diagnosis and treatment of Lyme Disease and Relapsing Fever
1540: Refreshments, posters and networking
1610: Professor Aidan Coffey, Cork Institute of Technology, Ireland
Title: Use of bacteriophage-derived peptidoglycan hydrolase enzymes to eliminate antibiotic resistant Staphylococcus aureus and Clostridium difficile
1640: Professor Valery Petrenko, Auburn College of Veterinary Medicine, USA
Title: Migrating phages selected from polyvalent ‘landscape’ phage display libraries as self-navigating drug-delivery vehicles
1710: Dr Krystyna Dąbrowska, Polish Academy of Sciences, Poland
Title: Phage penetration of animals and humans and immune responses
1740: Close of Day 1
1900: Networking Dinner (by prior booking or invitation only)
Day 2: Thursday 14th September
Session 4: Food and Biotechnology
Chair:
0930: Miss Ifigeneia Kyrkou, Aarhus University, Denmark
Title: Bacteriophages of wine starters revisited; isolation and characterization of new phages and their potential for a “green” wine production
0950: Dr Jennifer Mahony, University College Cork, Ireland
Title: Phage Biodiversity in Artisanal Cheese Wheys
1020: Dr Catherine Rees, University of Nottingham, UK
Title: TBA
1050: Refreshments, posters and networking
Session 5: Commercialisation and patenting of phage-based products
Chair:
1120: Dr Philip Webber, Dehns Patent and Trade Mark Attorneys, UK
Title: Patenting of phage-based therapies
1140: Dr Craig Thomson (HGF Limited, Patent and Trade Mark Attorneys ) and Professor Martha Clokie (University of Leicester, UK)
Title: Creating Impact: The challenges and opportunities of commercialisation in the field of bacteriophage research
Session 6: Methods, technologies, models
Chair: Professor Marth Clokie
1210: Dr Anders Nilsson, Stockholm University, Sweden
Title: Fine tuning of a mathematical model of phage infection
1240: Lunch, posters and networking
1330: Mr Junaid Ali, Loughborough University, UK
Title: Improving the bioprocess to increase phage titre
1350: Dr Christopher Turkington, University of Leicester, UK
Title: Isolation of bacteriophage of Haemophilus influenzae and Moraxella catarrhalis for the development of a culture independent quantification assay
1410: Dr Janet Nale, University of Leicester, UK, UK
Title: Galleria mellonella: A potentially useful in vivo model for Clostridium difficile infection and phage therapy
1430: Professor Petar Knezevic, University of Novi Sad, Serbia and Montenegro
Title: Safety assessment of phage Delta (vB_PaeP_Delta) application as anti-Pseudomonas agent
1450: Closing remarks by Professor Martha Clokie
1500: Close of conference
